Limiting the morbidity of inguinal lymphadenectomy for metastatic melanoma

Cancer Control

Volumn 16, Issue 3, 2009, Pages 240-247

  Sarnaik, Amod A ^a,b   Puleo, Christopher A ^a   Zager, Jonathan S ^a,b   Sondak, Vernon K ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; CERVICAL LYMPHADENOPATHY; DEEP VEIN THROMBOSIS; EARLY DIAGNOSIS; HUMAN; INGUINAL LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHEDEMA; MELANOMA; MINIMALLY INVASIVE PROCEDURE; MORBIDITY; PELVIS LYMPHADENECTOMY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; REVIEW; SAPHENOUS VEIN; SARTORIUS MUSCLE; SURGICAL TECHNIQUE;

EID: 67650535301     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480901600306     Document Type: Review

References (15)

1. Sabel MS, Griffith KA, Arora A, et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery. 2007;141(6): 728-735. (Pubitemid 46856567)
2. Nathansohn N, Schachter J, Gutman H. Patterns of recurrence in patients with melanoma after radical lymph node dissection. Arch Surg. 2005;140(12):1172-1177. (Pubitemid 41815899)
3. Landry CS, McMasters KM, Scoggins CR. The evolution of the management of regional lymph nodes in melanoma. J Surg Oncol. 2007;96(4): 316-321. (Pubitemid 47509766)
4. Janetschek G, Hobisch A, Peschel R, et al. Laparoscopic retroperitoneal lymph node dissection. Urology. 2000;55(1):136-140. (Pubitemid 30050777)
5. Karakousis CP, Emrich LJ, Rao U. Groin dissection in malignant melanoma. Am J Surg. 1986;152(5):491-495.
6. Karakousis CP, Driscoll DL. Groin dissection in malignant melanoma. Br J Surg. 1994;81(12):1771-1774.
7. Kretschmer L, Neumann C, Preusser K, et al. Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin: an analysis of survival and local recurrence. Acta Oncol. 2001;40(1):72-78. (Pubitemid 32234596)
8. Essner R, Scheri R, Kavanagh M, et al. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. Arch Surg. 2006;141(9):877-882; discussion 882-884. (Pubitemid 44414432)
9. Strobbe LJ, Jonk A, Hart AA, et al. The value of Cloquet's node in predicting melanoma nodal metastases in the pelvic lymph node basin. Ann Surg Oncol. 2001;8(3):209-214. (Pubitemid 32294800)
10. Badgwell B, Xing Y, Gershenwald JE, et al. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma. Ann Surg Oncol. 2007;14(10):2867-2875. Epub 2007 Aug 1. (Pubitemid 47460657)
11. Hughes TM, A'Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg. 2000;87(7):892-901. (Pubitemid 30487692)
12. Judson PL, Jonson AL, Paley PJ, et al. A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy. Gynecol Oncol. 2004;95(1):226-230. (Pubitemid 39286302)
13. Dardarian TS, Gray HJ, Morgan MA, et al. Saphenous vein sparing during inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma. Gynecol Oncol. 2006;101(1):140-142. Epub 2005 Dec 20. (Pubitemid 43303573)
14. Ko DS, Lerner R, Klose G, et al. Effective treatment of lymphedema of the extremities. Arch Surg. 1998;133(4):452-458.
15. Arbeit JM, Lowry SF, Line BR, et al. Deep venous thromboembolism in patients undergoing inguinal lymph node dissection for melanoma. Ann Surg. 1981;194(5):648-655. (Pubitemid 11026454)